Condition: Basal Cell Carcinoma Intervention: Drug: sonidegib Sponsor: Sun Pharmaceutical Industries Limited Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
23h
Conditions: Pediatric Cancer; Palliative Intervention: Other: Palliative home visit Sponsor: Indonesia University Active, not recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Fecal Incontinence; Low Anterior Resection Syndrome; Malignant Anal Neoplasm; Malignant Bladder Neoplasm; Malignant Cervical Neoplasm; Malignant Ovarian Neoplasm; Malignant Pelvic Neoplasm; Malignant Prostate Neoplasm; Malignant Uterine Neoplasm; Mali gnant Vaginal Neoplasm; Malignant Vulvar Neoplasm; Rectal Adenocarcinoma; Stage III Rectal Cancer AJCC v8; Stage IIIA Rectal Cancer AJCC v8; Stage IIIB Rectal Cancer AJCC v8; Stage IIIC Rectal Cancer AJCC v8;...
23h
Conditions: Childhood Cancer; Survivorship; Sexual Dysfunction Intervention: Other: Interviews Sponsors: University of Colorado, Denver; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Advanced Hepatocellular Carcinoma Interventions: Dietary Supplement: Oligo Fucoidan; Dietary Supplement: Placebo Sponsor: Hi-Q Marine Biotech International, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Advanced Malignant Neoplasm Intervention: Drug: KO-539 Sponsor: Kura Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer Interventions: Other: Chatbot; Other: Video Education; Other: In Person Genetic Counseling Sponsor: Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Carcinoma, Hepatocellular Interventions: Device: TACE; Drug: Anlotinib Hydrochloride Sponsor: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Colo-rectal Cancer; Colon Cancer; Diet Habit Intervention: Other: Walnuts Sponsors: UConn Health; American Institute for Cancer Research; California Walnut Commission; The Jackson Laboratory Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Cancer; Cancer Cachexia; Inflammation; Muscular Atrophy Interventions: Other: WB-EMS (Sham-intervention); Other: WB-EMS; Other: Free WB-EMS; Other: Flexi band resistance training Sponsor: University of Erlangen-Nürnberg Medical School Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
23h
Conditions: Chemotherapy-induced Peripheral Neuropathy; Breast Cancer Female; Gynecologic Cancer Intervention: Device: Acupuncture Sponsors: University of Utah; Annie Budhathoki, DAOM, LAc; Anna Beck, MD; Jeff Anderson, MD, PhD; Lynn Henry, MD Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Ewing Sarcoma Interventions: Drug: Trabectedin 1 MG [Yondelis]; Drug: Irinotecan; Diagnostic Test: tumor biopsy; Other: 3'-Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging Sponsors: Sarcoma Alliance for Research through Collaboration; Janssen Scientific Affairs, LLC; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Cancer; Kidney Diseases; Heart Failure; Neurologic Disorder; Liver Diseases; Pulmonary Disease; Side Effect; Quality of Life; Physical Disorder Intervention: Sponsor: Rigshospitalet, Denmark Enrolling by invitation (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
23h
Conditions: Breast Cancer; Non-small Cell Lung Cancer; Prostate Cancer; Ovarian Cancer; Head and Neck Cancer; Gastric Cancer; Esophageal Cancer Intervention: Sponsor: Samyang Biopharmaceuticals Corporation Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Refractory Ventricular Tachycardia Intervention: Procedure: SBRT Sponsors: Centro Cardiologico Monzino; Istituto Europeo di Oncologia Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer Interventions: Drug: M7824; Drug: Placebo; Drug: Gemcitabine; Drug: Cisplatin Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Urothelial Carcinoma Intervention: Drug: Cabozantinib Sponsors: Johannes Gutenberg University Mainz; Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Breast Cancer Interventions: Drug: Pyrotinib; Drug: nab-Paclitaxel; Drug: Trastuzumab; Drug: EC chemotherapy; Procedure: Surgery Sponsors: Shanghai Jiao Tong University School of Medicine; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm...
23h
Condition: Cancer Interventions: Other: Patient-reported outcomes assessment; Other: CTCAE rating; Other: PRO data is displayed Sponsors: Medical University Innsbruck; Complejo Hospitalario de Navarra; Centre Hospitalier Universitaire de Besancon; University of Leeds; VU University Medical Center; The Leeds Teaching Hospitals NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Triple Negative Breast Cancer Interventions: Drug: Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide; Drug: paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide Sponsor: Hebei Medical University Fourth Hospital Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Radiodermatitis; Injury, Radiation Interventions: Other: Spray skin protector; Other: moisturizer containing in its composition calendula officinalis Sponsor: Instituto Nacional de Cancer, Brazil Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: SBRT; Radical Prostatectomy Intervention: Radiation: SBRT Sponsor: Sunnybrook Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Metastatic Prostate Cancer Intervention: Sponsors: University College, London; Epic Sciences Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
23h
Condition: Classical Hodgkin Lymphoma Interventions: Drug: Camrelizumab; Drug: Epirubicin; Drug: Vincristine; Drug: Dacarbazine Sponsor: Henan Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Neoplasms; Neoplasm Malignant Intervention: Other: Rapid Evaporative Ionisation Mass Spectrometry (REIMS) Sponsor: Imperial College London Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Breast Cancer; Quality of Life; Physical Activity Intervention: Behavioral: Exercise Intervention Sponsors: University of California, San Diego; Haus of Volta Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Small Intestinal NET; Carcinoid Heart Disease Interventions: Drug: Telotristat Ethyl; Drug: Lanreotide Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Gastric Cancer Interventions: Drug: Sintilimab; Drug: Oxaliplatin; Drug: Capecitabine Sponsor: First Affiliated Hospital of Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Child; Determinants of Health; Qualitative Research; Cancer Intervention: Sponsors: University Hospital, Clermont-Ferrand; Université d'Auvergne Recruiting (Source: ClinicalTrials.gov)
23h
Conditions: Cancer; Cancer Cachexia; Inflammation Interventions: Other: Resistance Training; Other: WB-EMS; Other: High-intensity interval training (HIIT); Other: Combined HIIT and Resistance Training (Combi) Sponsor: University of Erlangen-Nürnberg Medical School Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
23h
Conditions: Multiple Myeloma; Relapsed Refractory Multiple Myeloma Interventions: Drug: Elotuzumab, pomalidomide, dexamethasone; Drug: Anti-LAG-3 Monoclonal Antibody BMS-986016, pomalidomide, dexamethasone; Drug: Anti-TIGIT Monoclonal Antibody BMS-986207, pomalidomide, dexamethasone Sponsors: Multiple Myeloma Research Consortium; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
23h
Condition: Gynaecological Cancers Interventions: Drug: AZD6738; Drug: Olaparib Sponsors: Institute of Cancer Research, United Kingdom; Cancer Research UK; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
23h
In the last few months, I have been bombarded daily by emails to participate in paid surveys for various market research firms. Some also invite me to review a certain number of charts./cases. These are all heme-onc based. As a poor fellow, if someone offers me >$100 to do something like this they at least have my attention. Anyone have experience with these? I haven't even gone through the screening questions on one to know if I could do it. (Source: Student Doctor Network)MedWorm Message:...
6h
(Source: BMJ Comments)
10h
Never really see the words "stereotactic ablative radiation therapy" in the popular press. A couple things I thought interesting were 1) it took 3 weeks to do the SABR (not "really" 5-or-less-fraction SABR? or did they just do very non-consecutive days?) and 2) they must have been obtaining screening CA 19-9 ("The abnormality was first detected after a routine blood test in early July")? Maybe? It would be a remarkable moment in the history of radiation oncology if SABR thwarted a... SABR + SCOTUS...
10h
New diagnoses of CVD, emphysema, osteoporosis identified, often are linked to adverse events (Source: Pulmonary Medicine News - Doctors Lounge)
7h
Last week, senior NHS bosses were ordered to repeat Prime Minister Boris Johnson’s claim that a no-deal Brexit must be carried out in October if necessary. As reported in The Independent, a controversial government briefing stated that all communications sent by NHS England must be “aligned to this script”. Labour’s Shadow Health Secretary, Jonathan Ashworth MP calls this a “gagging order” on NHS managers. The NHS Confederation have previously outlined several risks to a no-deal Brexit, namely...
7h
£18m funding for cancer support workers Related items fromOnMedica Better cancer treatment remains a ‘major’ public ‘priority’ Obesity as cause of cancer set to overtake smoking Is the NHS ready for ‘Cutting edge’ CAR T cell immunotherapy? Scotland launches its ‘Detect Cancer Early’ campaign Cancer patients using complementary meds die sooner (Source: OnMedica Latest News)
7h
Best practice to be shared across cancer networks Related items fromOnMedica Exercise and psychological treatments cut cancer fatigue Cancer patients using complementary meds die sooner Data don ’t support HRT for chronic disease prevention Benefit of Herceptin in more breast cancer cases New breast cancer drug ‘unaffordable’ for NHS (Source: OnMedica Latest News)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best...
7h
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου